Alpharetta Newswire

Alpharetta Newswire

Comprehensive Real-Time News Feed for Alpharetta, GA.

Results 1 - 20 of 62 for "u:americanbankingnews.com" in Alpharetta, GA

  1. Equities Research Analysts' Updated EPS Estimates for January, 17th ...Read the original story w/Photo

    Jan 17, 2017 | AmericanBankingNews.com

    Zacks Investment Research currently has $58.00 target price on the stock. According to Zacks, "Atlas Air Worldwide Holdings, Inc. is the parent company of Atlas Air and Polar Air Cargo, which together operate the world's largest fleet of Boeing freighter aircraft.

    Comment?

  2. Alimera Sciences, Inc. (ALIM) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Jan 17, 2017 | AmericanBankingNews.com

    According to Zacks, "Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity.

    Comment?

  3. Zacks Investment Research Upgrades Neenah Paper, Inc. (NP) to HoldRead the original story w/Photo

    Jan 15, 2017 | AmericanBankingNews.com

    According to Zacks, "Neenah is a leading global specialty materials company, focused on premium niche markets that include advanced filtration media, specialized substrates used for tapes, labels and other products, and premium printing and packaging papers. The company is headquartered in Alpharetta, Georgia and its products are sold in over 70 countries worldwide from manufacturing operations in the United States and Germany.

    Comment?

  4. Clearside Biomedical, Inc. (CLSD) Downgraded by Zacks Investment ResearchRead the original story w/Photo

    Jan 10, 2017 | AmericanBankingNews.com

    According to Zacks, "Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration.

    Comment?

  5. Halyard Health, Inc. (HYH) Upgraded to "Buy" at Zacks Investment ResearchRead the original story w/Photo

    Jan 8, 2017 | AmericanBankingNews.com

    The firm currently has a $41.00 price target on the stock. Zacks Investment Research's target price would suggest a potential upside of 8.55% from the company's current price.

    Comment?

  6. Halyard Health, Inc. (HYH) Rating Lowered to Hold at Zacks Investment ResearchRead the original story w/Photo

    Jan 5, 2017 | AmericanBankingNews.com

    According to Zacks, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery.

    Comment?

  7. Neenah Paper, Inc. (NP) Downgraded by Zacks Investment Research to Strong SellRead the original story w/Photo

    Jan 4, 2017 | AmericanBankingNews.com

    According to Zacks, "Neenah is a leading global specialty materials company, focused on premium niche markets that include advanced filtration media, specialized substrates used for tapes, labels and other products, and premium printing and packaging papers. The company is headquartered in Alpharetta, Georgia and its products are sold in over 70 countries worldwide from manufacturing operations in the United States and Germany.

    Comment?

  8. Alimera Sciences Inc. (ALIM) Rating Increased to Hold at Zacks Investment ResearchRead the original story w/Photo

    Nov 29, 2016 | AmericanBankingNews.com

    According to Zacks, "Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity.

    Comment?

  9. Analysts' Updated EPS Estimates for November, 29th (AEO, ALIM,...Read the original story

    Nov 29, 2016 | AmericanBankingNews.com

    According to Zacks, "Alimera Sciences, Inc., based in Alpharetta, Georgia, is a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company is presently focused on diseases affecting the back of the eye, or retina because it believes these diseases are not well treated with current therapies and represent a significant market opportunity.

    Comment?

  10. Zacks Investment Research Upgrades Neenah Paper Inc. (NP) to HoldRead the original story w/Photo

    Nov 24, 2016 | AmericanBankingNews.com

    According to Zacks, "Neenah is a leading global specialty materials company, focused on premium niche markets that include advanced filtration media, specialized substrates used for tapes, labels and other products, and premium printing and packaging papers. The company is headquartered in Alpharetta, Georgia and its products are sold in over 70 countries worldwide from manufacturing operations in the United States and Germany.

    Comment?

  11. Halyard Health Inc. (HYH) Lowered to "Hold" at Zacks Investment ResearchRead the original story w/Photo

    Nov 22, 2016 | AmericanBankingNews.com

    According to Zacks, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery.

    Comment?

  12. Halyard Health Inc. (HYH) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Nov 22, 2016 | AmericanBankingNews.com

    According to Zacks, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery.

    Comment?

  13. Halyard Health Inc. (HYH) Raised to "Buy" at Zacks Investment ResearchRead the original story

    Nov 21, 2016 | AmericanBankingNews.com

    The firm currently has a $41.00 target price on the stock. Zacks Investment Research's price objective indicates a potential upside of 11.56% from the company's current price.

    Comment?

  14. Clearside Biomedical Inc. (CLSD) Raised to Buy at Zacks Investment ResearchRead the original story w/Photo

    Nov 11, 2016 | AmericanBankingNews.com

    The firm currently has a $22.00 price objective on the stock. Zacks Investment Research's price target indicates a potential upside of 10.83% from the company's current price.

    Comment?

  15. Investment Analysts' Weekly Ratings Changes for Clearside BiomedicalRead the original story w/Photo

    Nov 11, 2016 | AmericanBankingNews.com

    They now have a $22.00 price target on the stock. According to Zacks, "Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space microinjector.

    Comment?

  16. Halyard Health Inc. (HYH) Upgraded by Zacks Investment Research to HoldRead the original story w/Photo

    Nov 4, 2016 | AmericanBankingNews.com

    According to Zacks, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery.

    Comment?

  17. Auto DraftRead the original story w/Photo

    Nov 4, 2016 | AmericanBankingNews.com

    According to Zacks, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery.

    Comment?

  18. Clearside Biomedical (CLSD) - Investment Analysts' Recent Ratings ChangesRead the original story w/Photo

    Nov 2, 2016 | AmericanBankingNews.com

    According to Zacks, "Clearside Biomedical, Inc. is a biopharmaceutical company is engaged in developing first-in-class drug therapies to treat blinding diseases of the eye using Clearside proprietary suprachoroidal space microinjector. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration.

    Comment?

  19. Neenah Paper Inc. (NP) Rating Lowered to Hold at Zacks Investment ResearchRead the original story w/Photo

    Oct 30, 2016 | AmericanBankingNews.com

    According to Zacks, "Neenah is a leading global specialty materials company, focused on premium niche markets that include advanced filtration media, specialized substrates used for tapes, labels and other products, and premium printing and packaging papers. The company is headquartered in Alpharetta, Georgia and its products are sold in over 70 countries worldwide from manufacturing operations in the United States and Germany.

    Comment?

  20. Analysts' Downgrades for October, 25thRead the original story w/Photo

    Oct 25, 2016 | AmericanBankingNews.com

    According to Zacks, "Arbutus Biopharma Corporation is a biopharmaceutical company which is focused on discovering, developing and commercializing a portfolio of drug candidates for chronic hepatitis B infection. The Company's products include TKM-HBV, Cyclophilin Inhibitor-OCB-030, TLR9 Agonist , Capsid Assembly Inhibitors, Surface Antigen Secretion Inhibitors, STING Agonists, cccDNA Formation Inhibitors, cccDNA Epigenetic Modifiers, TKM-PLK1, GI-NET and ACC, HCC, TKM-Ebola, TKM-Ebola-Guinea, TKM-Marburg, TKM-HTG and TKM-ALDH which are in different clinical trial stage.

    Comment?

Alpharetta Job Listings
View or post Alpharetta job listings on Topix.
Alpharetta Real Estate
News, listings, and foreclosures in Alpharetta from Topix.
Alpharetta Mortgages
Find mortgage rates in Alpharetta on Topix.